<?xml version="1.0" encoding="UTF-8"?>
<html><body class="spl" id="spl">
<div class="DocumentTitle"><p class="DocumentTitle"><strong>FLUOROPLEX- fluorouracil cream </strong><br>Aqua Pharmaceuticals, LLC<br></p></div>
<h1>Fluoroplex<span class="Sup">®</span><br> (fluorouracil) 1% <br> Topical Cream</h1>
<div class="Contents">
<div class="Section" data-sectionCode="48780-1">
<a name="DLDE"></a><a name="section-1"></a><p></p>
</div>
<div class="Section" data-sectionCode="34089-3">
<a name="section-1"></a><p></p>
<h1>DESCRIPTION</h1>
<p class="First">FLUOROPLEX<span class="Sup">®</span> (fluorouracil) 1% Topical Cream is an antineoplastic/antimetabolite product for dermatological use. Fluorouracil has the empirical formula C<span class="Sub">4</span>H<span class="Sub">3</span>FN<span class="Sub">2</span>O<span class="Sub">2</span> and a molecular weight of 130.08. It is sparingly soluble in water and slightly soluble in alcohol. The pH is approximately 8.5.</p>
<p><span class="Bold">Structural Formula:</span></p>
<div class="Figure">
<img alt="Chemical Structure" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=258bb79a-56b3-4f46-ade6-7331ec031074&amp;name=fluoroplex-01.jpg"><p class="MultiMediaCaption">fluorouracil</p>
</div>
<p><span class="Bold">Chemical Name:</span><br>2,4(1H,3H)-Pyrimidinedione, 5-fluoro-.</p>
<p>FLUOROPLEX<span class="Sup">®</span> 1% Topical Cream contains:</p>
<p><span class="Bold">Active Ingredient:</span> fluorouracil 1.0%</p>
<p><span class="Bold">Inactive Ingredients:</span> benzyl alcohol, emulsifying wax, isopropyl myristate, mineral oil, purified water, and sodium hydroxide.</p>
</div>
<div class="Section" data-sectionCode="34090-1">
<a name="section-2"></a><p></p>
<h1>CLINICAL PHARMACOLOGY</h1>
<p class="First">There is evidence that fluorouracil (or its metabolites) blocks the methylation reaction of deoxyuridylic acid to thymidylic acid. In this fashion, fluorouracil interferes with the synthesis of deoxyribonucleic acid (DNA) and to a lesser extent inhibits the formation of ribonucleic acid (RNA).</p>
</div>
<div class="Section" data-sectionCode="34067-9">
<a name="section-3"></a><p></p>
<h1>INDICATIONS AND USAGE</h1>
<p class="First">FLUOROPLEX<span class="Sup">®</span> Cream is indicated for the topical treatment of multiple actinic (solar) keratoses.</p>
</div>
<div class="Section" data-sectionCode="34070-3">
<a name="section-4"></a><p></p>
<h1>CONTRAINDICATIONS</h1>
<p class="First">Fluorouracil is contraindicated in women who are or may become pregnant.</p>
<p>This product should not be used by patients who are allergic to any of its components.</p>
</div>
<div class="Section" data-sectionCode="34071-1">
<a name="section-5"></a><p></p>
<h1>WARNINGS</h1>
<p class="First">There exists the potential for a delayed <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity reaction</span> to fluorouracil. Patch testing to prove <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">hypersensitivity</span> may be inconclusive<span class="Sup">1</span>.</p>
<p>If an occlusive dressing is used, there may be an increase in the incidence of <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammatory reactions</span> in the adjacent normal skin.</p>
<p>The patient should avoid prolonged exposure to sunlight or other forms of ultraviolet irradiation during treatment with FLUOROPLEX<span class="Sup">®</span> Cream, as the intensity of the reaction may be increased.</p>
</div>
<div class="Section" data-sectionCode="42232-9">
<a name="section-6"></a><p></p>
<h1>PRECAUTIONS</h1>
<div class="Section" data-sectionCode="34072-9">
<a name="general"></a><a name="section-6.1"></a><p></p>
<h2>General</h2>
<p class="First">There is a possibility of increased absorption through ulcerated or inflamed skin.</p>
</div>
<div class="Section" data-sectionCode="34076-0">
<a name="section-6.2"></a><p></p>
<h2>Information for patients</h2>
<p class="First">The medication should be applied with care near the eyes, nose, and mouth. Excessive reaction in these areas may occur due to irritation from accumulation of drug. FLUOROPLEX<span class="Sup">®</span> Cream is applied with the fingers, and the hands should be washed immediately afterward. The reaction to FLUOROPLEX<span class="Sup">®</span> Cream in treated areas may be unsightly during therapy, and, in some cases, for several weeks following cessation of therapy.</p>
</div>
<div class="Section" data-sectionCode="34075-2">
<a name="section-6.3"></a><p></p>
<h2>Laboratory Tests</h2>
<p class="First">To rule out the presence of a frank neoplasm, a biopsy should be made of those areas failing to respond to treatment or recurring after treatment.</p>
</div>
<div class="Section" data-sectionCode="34083-6">
<a name="section-6.4"></a><p></p>
<h2>Carcinogenesis, mutagenesis, impairment of fertility</h2>
<p class="First">Adequate long-term studies in animals to evaluate carcinogenic potential have not been conducted with fluorouracil. In three <span class="Italics">in-vitro</span> cell transformation assays, fluorouracil produced morphological transformation of cells. Morphological transformation was also produced in one of these <span class="Italics">in-vitro</span> assays by a metabolite of fluorouracil and the transformed cells produced <span class="product-label-link" type="condition" conceptid="197506" conceptname="Malignant neoplasm of abdomen">malignant tumors</span> when injected into immunosuppressed syngeneic mice. Fluorouracil has been shown to exert mutagenic acitivity in the yeast cells, Bacillus subtilis and Drosophila assays. In addition, fluorouracil has produced chromosome damage at concentrations of 1.0 and 2.0 mcg/mL in an <span class="Italics">in vitro</span> hamster fibroblast assay and increases in micronuclei formation in the bone marrow of mice at intraperitoneal doses within the human therapeutic dose range of 12-15 mg/kg/day. Patients receiving cumulative doses of 0.24-1.0 g of fluorouracil parenterally have shown an increase in numerical and structural chromosome aberrations in peripheral blood <span class="product-label-link" type="condition" conceptid="4254663" conceptname="Lymphocyte count">lymphocytes</span>. Fluorouracil has been shown to impair fertility after parenteral administration in rats. In mice, single-dose intravenous and intraperitoneal injections of fluorouracil have been reported to kill differentiated spermatogonia and spermatocytes at a dose of 500 mg/kg and produce abnormalities in spermatids at 50 mg/kg.</p>
<p>Fluorouracil was negative in the dominant lethal mutation assay performed in mice.</p>
</div>
<div class="Section" data-sectionCode="42228-7">
<a name="section-6.5"></a><p></p>
<h2>Pregnancy</h2>
<div class="Section" data-sectionCode="34077-8">
<a name="section-6.5.1"></a><p></p>
<h3>Teratogenic Effects</h3>
<div class="Section" data-sectionCode="42229-5">
<a name="section-6.5.1.1"></a><p></p>
<h4>Pregnancy Category X</h4>
<p class="First">Fluorouracil may cause fetal harm when administered to a pregnant woman. Fluorouracil administered parenterally has been shown to be teratogenic in mice, rats and hamsters, and embryolethal in monkeys. Fluorouracil is contraindicated in women who are or may become pregnant. If this drug is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus.</p>
</div>
</div>
</div>
<div class="Section" data-sectionCode="34080-2">
<a name="section-6.6"></a><p></p>
<h2>Nursing mothers</h2>
<p class="First">It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, and because there is some systemic absorption of fluorouracil after topical administration (see <span class="Bold"><a href="#general">PRECAUTIONS: General</a></span>), mothers should not nurse their infants while receiving this drug.</p>
</div>
<div class="Section" data-sectionCode="34081-0">
<a name="section-6.7"></a><p></p>
<h2>Pediatric use</h2>
<p class="First">Safety and effectiveness in pediatric patients have not been established.</p>
</div>
</div>
<div class="Section" data-sectionCode="34084-4">
<a name="section-7"></a><p></p>
<h1>ADVERSE REACTIONS</h1>
<p class="First"><span class="product-label-link" type="condition" conceptid="4329041" conceptname="Pain">Pain</span>, <span class="product-label-link" type="condition" conceptid="4169287" conceptname="Itching of skin">pruritus</span>, burning, irritation, <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammation</span>, <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">allergic contact dermatitis</span> and <span class="product-label-link" type="condition" conceptid="4010094" conceptname="Telangiectasis">telangiectasia</span> have been reported. Occasionally, hyperpigmentation and <span class="product-label-link" type="condition" conceptid="4050007" conceptname="Scar">scarring</span> have also been reported.</p>
</div>
<div class="Section" data-sectionCode="34088-5">
<a name="section-8"></a><p></p>
<h1>OVERDOSAGE</h1>
<p class="First">Ordinarily, overdosage will not cause acute problems. If FLUOROPLEX<span class="Sup">®</span> Cream accidentally comes in contact with the eye(s), flush the eyes(s) with water or normal saline. If FLUOROPLEX<span class="Sup">®</span> Cream is accidentally ingested, induce <span class="product-label-link" type="condition" conceptid="441408" conceptname="Vomiting">emesis</span> and gastric lavage. Administer symptomatic and supportive care as needed.</p>
</div>
<div class="Section" data-sectionCode="34068-7">
<a name="section-9"></a><p></p>
<h1>DOSAGE AND ADMINISTRATION</h1>
<p class="First">The patient should be instructed to apply sufficient medication to cover the entire face or other affected areas.</p>
<p>Apply medication twice daily with fingertips and wash hands afterwards. A treatment period of 2-6 weeks is usually required.</p>
<p>Increasing the frequency of application and a longer period of administration with FLUOROPLEX<span class="Sup">®</span> Cream may be required on areas other than the head and neck.</p>
<p>When FLUOROPLEX<span class="Sup">®</span> Cream is applied to keratotic skin, a response occurs with the following sequence: <span class="product-label-link" type="condition" conceptid="137193" conceptname="Erythema">erythema</span>, usually followed by scaling, <span class="product-label-link" type="condition" conceptid="4082445" conceptname="Tenderness">tenderness</span>, erosion, ulceration, <span class="product-label-link" type="condition" conceptid="4280654" conceptname="Necrosis">necrosis</span> and re-epithelization. When the <span class="product-label-link" type="condition" conceptid="4053015" conceptname="Inflammation">inflammatory reaction</span> reaches the erosion, ulceration and <span class="product-label-link" type="condition" conceptid="4280654" conceptname="Necrosis">necrosis</span> stages, the use of the drug should be terminated. Responses may sometimes occur in areas which appear clinically normal. These may be sites of subclinical actinic (solar) <span class="product-label-link" type="condition" conceptid="4098436" conceptname="Hyperkeratosis">keratosis</span> which the medication is affecting.</p>
</div>
<div class="Section" data-sectionCode="34069-5">
<a name="section-10"></a><p></p>
<h1>HOW SUPPLIED</h1>
<p class="First">FLUOROPLEX<span class="Sup">®</span> (fluorouracil) 1% Topical Cream is available in 30 g tubes (NDC 16110-812-30)</p>
<div class="Section" data-sectionCode="44425-7">
<a name="section-10.1"></a><p></p>
<p class="First"><span class="Bold">NOTE:</span> Avoid freezing. Store at 15° - 30°C (59° - 86°F) in tight containers.</p>
<p><span class="Bold">Rx Only</span></p>
</div>
</div>
<div class="Section" data-sectionCode="34093-5">
<a name="section-11"></a><p></p>
<h1>REFERENCE</h1>
<ol class="Numeric"><li>Epstein E. Testing for 5-fluorouracil <span class="product-label-link" type="condition" conceptid="4084167" conceptname="Acute allergic reaction">allergy</span>: patch and intradermal tests. <span class="product-label-link" type="condition" conceptid="134438" conceptname="Contact dermatitis">Contact Dermatitis</span> 1984; 10:311.</li></ol>
</div>
<div class="Section" data-sectionCode="42229-5">
<a name="section-12"></a><p></p>
<p class="First"><span class="Bold">Revised March 2012</span></p>
<p>Manufactured for:<br>Aqua Pharmaceuticals<br>West Chester, PA 19380, U.S.A.<br>By:<br>Contract Pharmaceuticals Limited<br>Mississauga<br>Ontario, Canada<br>L5N 6L6<br>® Marks owned by Aqua Pharmaceuticals<br>Printed in U.S.A.</p>
<p>4716X<br>2005931</p>
</div>
<div class="Section" data-sectionCode="51945-4">
<a name="section-13"></a><p></p>
<h1>PRINCIPAL DISPLAY PANEL - 30 g Tube Carton</h1>
<p class="First">30 grams</p>
<p><span class="Bold">Fluoroplex</span><span class="Sup">®</span><br>(fluorouracil) 1%<br>Topical Cream</p>
<p>NDC 16110-812-30</p>
<p><span class="Bold">Contains:<br>Active:</span> fluorouracil 1.0%<br><span class="Bold">Inactives:</span> benzyl alcohol; emulsifying wax; mineral<br>oil; isopropyl myristate; sodium hydroxide; and<br>purified water.</p>
<p>Rx Only</p>
<p><span class="Bold">AQUA</span><br>PHARMACEUTICALS</p>
<div class="Figure"><img alt="PRINCIPAL DISPLAY PANEL - 30 g Tube Carton" src="http://dailymed.nlm.nih.gov/dailymed/image.cfm?setid=258bb79a-56b3-4f46-ade6-7331ec031074&amp;name=fluoroplex-02.jpg"></div>
</div>
</div>
<div class="DataElementsTables">
<table class="contentTablePetite" cellSpacing="0" cellPadding="3" width="100%"><tbody>
<tr><td class="contentTableTitle">
<strong>FLUOROPLEX 		
					</strong><br><span class="contentTableReg">fluorouracil cream</span>
</td></tr>
<tr><td><table width="100%" cellpadding="5" cellspacing="0" class="formTablePetite">
<tr><td colspan="4" class="formHeadingTitle">Product Information</td></tr>
<tr class="formTableRowAlt">
<td class="formLabel">Product Type</td>
<td class="formItem">HUMAN PRESCRIPTION DRUG LABEL</td>
<td class="formLabel">Item Code (Source)</td>
<td class="formItem">NDC:16110-812</td>
</tr>
<tr class="formTableRow">
<td width="30%" class="formLabel">Route of Administration</td>
<td class="formItem">TOPICAL</td>
<td width="30%" class="formLabel">DEA Schedule</td>
<td class="formItem">    
							</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="3" class="formHeadingTitle">Active Ingredient/Active Moiety</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Basis of Strength</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">
<strong>fluorouracil</strong> (fluorouracil) </td>
<td class="formItem">fluorouracil</td>
<td class="formItem">10 mg  in 1 g</td>
</tr>
</table></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="2" class="formHeadingTitle">Inactive Ingredients</td></tr>
<tr>
<th class="formTitle" scope="col">Ingredient Name</th>
<th class="formTitle" scope="col">Strength</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>benzyl alcohol</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>ISOPROPYL MYRISTATE</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>mineral oil</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRow">
<td class="formItem"><strong>water</strong></td>
<td class="formItem"> </td>
</tr>
<tr class="formTableRowAlt">
<td class="formItem"><strong>sodium hydroxide</strong></td>
<td class="formItem"> </td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td><table width="100%" cellpadding="3" cellspacing="0" class="formTablePetite">
<tr><td colspan="5" class="formHeadingTitle">Packaging</td></tr>
<tr>
<th scope="col" width="1" class="formTitle">#</th>
<th scope="col" class="formTitle">Item Code</th>
<th scope="col" class="formTitle">Package Description</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem">NDC:16110-812-30</td>
<td class="formItem">1  in 1 CARTON</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
<tr class="formTableRowAlt">
<th scope="row" class="formItem">1</th>
<td class="formItem"></td>
<td class="formItem">30 g in 1 TUBE</td>
<td class="formItem"></td>
<td class="formItem"></td>
</tr>
</table></td></tr>
<tr><td></td></tr>
<tr><td class="normalizer"><table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Marketing Information</span></td></tr>
<tr>
<th scope="col" class="formTitle">Marketing Category</th>
<th scope="col" class="formTitle">Application Number or Monograph Citation</th>
<th scope="col" class="formTitle">Marketing Start Date</th>
<th scope="col" class="formTitle">Marketing End Date</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">NDA</td>
<td class="formItem">NDA016988</td>
<td class="formItem">12/03/1993</td>
<td class="formItem"></td>
</tr>
</table></td></tr>
</tbody></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite"><tr><td colspan="4" class="formHeadingReg">
<span class="formHeadingTitle">Labeler - </span>Aqua Pharmaceuticals, LLC
							(605425912)
						</td></tr></table>
<table width="100%" cellpadding="3" cellspacing="0" class="formTableMorePetite">
<tr><td colspan="4" class="formHeadingReg"><span class="formHeadingTitle">Establishment</span></td></tr>
<tr>
<th scope="col" class="formTitle">Name</th>
<th scope="col" class="formTitle">Address</th>
<th scope="col" class="formTitle">ID/FEI</th>
<th scope="col" class="formTitle">Business Operations</th>
</tr>
<tr class="formTableRowAlt">
<td class="formItem">Contract Pharmaceuticals Limited Canada</td>
<td class="formItem"></td>
<td class="formItem">248761249</td>
<td class="formItem">MANUFACTURE(16110-812), PACK(16110-812), ANALYSIS(16110-812)</td>
</tr>
</table>
</div>
<p><div class="EffectiveDate">Revised: 11/2012<div class="DocumentMetadata">
<div>
<a href="javascript:toggleMixin();">Document Id: </a>2262f565-8046-41b1-a62c-aac3ef2de03d</div>
<div>Set id: 258bb79a-56b3-4f46-ade6-7331ec031074</div>
<div>Version: 1</div>
<div>Effective Time: 20121112</div>
</div>
</div> <div class="DistributorName">Aqua Pharmaceuticals, LLC</div></p>
</body></html>
